s6y
Company name or ticker
Search
Dyne Therapeutics, Inc.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Wednesday, July 22, 2026
Accession number
0001193125-26-312576
Documents
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Certifications, consents and other formalities
1
Filing fee table
Filing fee table
EX-FILING FEES
On sec.gov
Filing index
All files
Complete submission text
SGML header